UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Acetylation of non-histone proteins modulates cellular signalling at multiple levels

The international journal of biochemistry & cell biology, 2009, Vol.41 (1), p.185-198

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis

PloS one, 2018-11, Vol.13 (11), p.e0207915-e0207915

2018

Link zum Volltext

Verfügbarkeit prüfen

Drugging the HDAC6–HSP90 interplay in malignant cells

Trends in pharmacological sciences (Regular ed.), 2014-10, Vol.35 (10), p.501-509

2014

Link zum Volltext

Verfügbarkeit prüfen

HDAC2: a critical factor in health and disease

Trends in pharmacological sciences (Regular ed.), 2009-12, Vol.30 (12), p.647-655

Krämer, Oliver H

2009

Link zum Volltext

Verfügbarkeit prüfen

Concepts to Target MYC in Pancreatic Cancer

Molecular cancer therapeutics, 2016-08, Vol.15 (8), p.1792-1798

2016

Link zum Volltext

Verfügbarkeit prüfen

Interstrand Crosslink Repair as a Target for HDAC Inhibition

Trends in pharmacological sciences (Regular ed.), 2017-09, Vol.38 (9), p.822-836

2017

Link zum Volltext

Verfügbarkeit prüfen

Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors

Journal of medicinal chemistry, 2018-04, Vol.61 (8), p.3454-3477

2018

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis

Biochimica et biophysica acta, 2014-12, Vol.1846 (2), p.524-538

2014

Link zum Volltext

Verfügbarkeit prüfen

HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130

Nature communications, 2018-02, Vol.9 (1), p.764-17, Article 764

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T‑Cell Prolymphocytic Leukemia

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8486-8509

2021

Link zum Volltext

Verfügbarkeit prüfen

The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation

Biochimica et biophysica acta. Reviews on cancer, 2020-12, Vol.1874 (2), p.188453, Article 188453

2020

Link zum Volltext

Verfügbarkeit prüfen

Survivin and YM155: How faithful is the liaison?

Biochimica et biophysica acta, 2014-04, Vol.1845 (2), p.202-220

2014

Link zum Volltext

Verfügbarkeit prüfen

The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration

Cytokine & growth factor reviews, 2017-10, Vol.37, p.29-45

2017

Link zum Volltext

Verfügbarkeit prüfen

Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor

Journal of medicinal chemistry, 2022-11, Vol.65 (21), p.14614-14629

2022

Link zum Volltext

Verfügbarkeit prüfen

HDACi – Targets beyond chromatin

Cancer letters, 2009-08, Vol.280 (2), p.160-167

2009

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation–acetylation switch in the regulation of STAT1 signaling

Molecular and cellular endocrinology, 2010-02, Vol.315 (1), p.40-48

2010

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance

Cancer research (Chicago, Ill.), 2016-05, Vol.76 (10), p.3067-3077

2016

Link zum Volltext

Verfügbarkeit prüfen

NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor

Cancers, 2023-07, Vol.15 (14), p.3650

2023

Link zum Volltext

Verfügbarkeit prüfen

Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling

Biochimica et biophysica acta. Reviews on cancer, 2017-08, Vol.1868 (1), p.29-39

2017

Link zum Volltext

Verfügbarkeit prüfen

STAT1‑HDAC4 signaling induces epithelial‑mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2

Oncology reports, 2018-11, Vol.40 (5), p.2619-2627

2018

Link zum Volltext

Verfügbarkeit prüfen

RNA interference protocol to silence oncogenic drivers in leukemia cell lines

STAR protocols, 2022-09, Vol.3 (3), p.101512-101512, Article 101512

2022

Link zum Volltext

Verfügbarkeit prüfen

News and views: AUTOTACs join the arena for targeted protein degradation

Archives of toxicology, 2022-07, Vol.96 (7), p.2143-2144

2022

Link zum Volltext

Verfügbarkeit prüfen

A phosphorylation-acetylation switch regulates STAT1 signaling

Genes & development, 2009-01, Vol.23 (2), p.223-235

2009

Link zum Volltext

Verfügbarkeit prüfen

Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors

European journal of medicinal chemistry, 2018-05, Vol.152, p.329-357

2018

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3

Leukemia, 2023-11, Vol.37 (11), p.2319-2323

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(777)
Mit Volltextzugriff
(1.153)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(640)
Life Sciences & Biomedicine
(326)
Technology
(275)
Computer Science
(269)
Computer Science, Artificial Intelligence
(239)
Humans
(237)
Computer Science, Information Systems
(150)
Animals
(102)
Male
(102)
Female
(92)
Artificial Intelligence
(62)
Middle Aged
(62)
Oncology
(62)
Cell Biology
(55)
Biochemistry & Molecular Biology
(51)
Apoptosis
(50)
Adult
(49)
Imaging Science & Photographic Technology
(48)
Aged
(45)
Biological And Medical Sciences
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(11)
Oncotarget
(10)
Alzheimer's & Dementia
(8)
Archives Of Toxicology
(7)
Nature Communications
(7)
Applied Computational Intelligence And Soft Computing
(6)
Blood
(6)
Cancer Research
(6)
The Faseb Journal
(6)
Transplant International
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Acetylation of non-histone proteins modulates cellular signalling at multiple levels

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis

Drugging the HDAC6–HSP90 interplay in malignant cells

HDAC2: a critical factor in health and disease

Concepts to Target MYC in Pancreatic Cancer

Interstrand Crosslink Repair as a Target for HDAC Inhibition

Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors

Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis

HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130

Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T‑Cell Prolymphocytic Leukemia

The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation

Survivin and YM155: How faithful is the liaison?

The interplay between histone deacetylases and rho kinases is important for cancer and neurodegeneration

Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor

HDACi – Targets beyond chromatin

Phosphorylation–acetylation switch in the regulation of STAT1 signaling

Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance

NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor

Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling

STAT1‑HDAC4 signaling induces epithelial‑mesenchymal transition and sphere formation of cancer cells overexpressing the oncogene, CUG2

RNA interference protocol to silence oncogenic drivers in leukemia cell lines

News and views: AUTOTACs join the arena for targeted protein degradation

A phosphorylation-acetylation switch regulates STAT1 signaling

Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors

Histone deacetylase inhibitors modulate hormesis in leukemic cells with mutant FMS-like tyrosine kinase-3

Suchergebnisse filtern